Inventor
WENNOGLE LAWRENCE
US17 patents
⚠️ This page may combine multiple inventors who share the name “WENNOGLE LAWRENCE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
INTRA CELLULAR THERAPIES INC
11 patentsUS9428506B2Aug 30, 2016
Substituted pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalines for the treatment of nervous system disorders
INTRA CELLULAR THERAPIES INC82 citations99
US11124514B2Sep 21, 2021
Compositions and methods
INTRA CELLULAR THERAPIES INC40 citations98
US9616061B2Apr 11, 2017
Methods and compositions for sleep disorders and other disorders
INTRA CELLULAR THERAPIES INC93 citations98
US11958852B2Apr 16, 2024
Compounds and methods
INTRA CELLULAR THERAPIES INC11 citations94
USRE48839EDec 7, 2021
Methods and compositions for sleep disorders and other disorders
INTRA CELLULAR THERAPIES INC21 citations93
US9598426B2Mar 21, 2017
Organic compounds
INTRA CELLULAR THERAPIES INC15 citations92
US9545406B2Jan 17, 2017
Method of treating a CNS injury with a PDE1 inhibitor
INTRA CELLULAR THERAPIES INC10 citations84
US10183023B2Jan 22, 2019
Uses
INTRA CELLULAR THERAPIES INC2 citations73
US10150774B2Dec 11, 2018
Compounds and methods
INTRA CELLULAR THERAPIES INC5 citations73
US12565499B2Mar 3, 2026
Compounds and methods
INTRA CELLULAR THERAPIES INC0 citations62
US11839614B2Dec 12, 2023
Methods for treating or mitigating cardiotoxicity characterized by inhibition of adenosine A2 signaling and/or adenosine A2 receptor expression
INTRA CELLULAR THERAPIES INC1 citations61
LI PENG
4 patentsUS8664207B2Mar 4, 2014
Organic compounds
LI PENG99 citations98
US8697710B2Apr 15, 2014
Optionally substituted 3-amino-4-(thioxo or imino)-4,5-dihydro-2H-pyrazolo [3,4-d]pyrimidin-6(7H)-ones
LI PENG96 citations97
US8633180B2Jan 21, 2014
Organic compounds
LI PENG97 citations97
US8536159B2Sep 17, 2013
Organic compounds
LI PENG98 citations97